Improving Glycemic Control in Adults and Children With Type 1 Diabetes With the Use of Smartphone-Based Mobile Applications: A Systematic Review

Canadian Journal of Diabetes
Cathy SunMary-Anne Doyle

Abstract

Management of type 1 diabetes is often challenging. Smartphone mobile applications (apps) may provide additional support and help to improve glycemic control and clinical outcomes. The objectives of this study were to examine the literature evaluating the use of mobile apps (stand-alone and text messaging/feedback) in type 1 diabetes and to review top-rated mobile apps applicable to type 1 diabetes. Medline, Cochrane and Embase databases were systematically searched to identify studies published from inception to February 2018. Top-rated relevant apps from Google Play Store and Apple App Store were reviewed in July 2017. The literature search yielded 3,462 studies. Of these studies, 9 evaluated the stand-alone apps; 3 showed significant improvement in glycated hemoglobin (A1C) levels (0.5%, p<0.05, 0.57%, p<0.05, and 0.58%, p=0.02); 3 demonstrated improved adherence to glucose monitoring; and 1 study demonstrated a reduction in hypoglycemic events (glucose<3.0 mmol/L) in 6 of 10 participants who completed the study. Also, 5 studies evaluated a mobile app plus text-messaging/feedback system. Only 1 showed a significant reduction in severe hypoglycemic events (mobile app+text, IQR 0.33, 95% CI 0.17 to 0.63; vs. control, IQR 2.29,...Continue Reading

Citations

Aug 24, 2019·Journal of Diabetes Science and Technology·Leah M WilsonJessica R Castle
Oct 11, 2019·Journal of the American Medical Informatics Association : JAMIA·Saba AkbarFarah Magrabi
Nov 13, 2019·Indian Journal of Pediatrics·Rajni Sharma
Oct 5, 2018·Current Diabetes Reports·Leslie EilandAndjela Drincic
Feb 16, 2021·JMIR MHealth and UHealth·Claudia EberleStefanie Stichling
Jul 2, 2021·European Journal of Pediatrics·Federico FerroOrsola Gawronski
Jun 1, 2021·Digital Biomarkers·Andrew LerouxTushar Sharma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.